Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS
…, B Aubry-Rozier, EF Eriksen, N Guañabens… - Bone, 2017 - Elsevier
… In a recent observational study (n = 82) bone loss after stopping denosumab after 8 years
was attenuated in the small number of patients (n = 17) who started osteoporosis medication, …
was attenuated in the small number of patients (n = 17) who started osteoporosis medication, …
Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS
…, LC Hofbauer, N Guañabens… - The Journal of …, 2021 - academic.oup.com
… (n = 27) or 2 additional 60 mg injections of denosumab (n = 30); both groups were
subsequently followed for a period of 24 months. At 24 months, BMD at the LS did not differ from …
subsequently followed for a period of 24 months. At 24 months, BMD at the LS did not differ from …
Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment
…, S Ralston, N Guañabens, N Migone… - Journal of medical …, 2006 - jmg.bmj.com
… N Guañabens7, … N Migone8, … in the part of exon 1 encoding the signal peptide, and two
missense mutations in exon 1 and exon 2 at the N-terminus of the latency associated peptide. …
missense mutations in exon 1 and exon 2 at the N-terminus of the latency associated peptide. …
Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial
…, J Carrasco, A Monegal, N Guañabens… - Journal of bone and …, 2012 - academic.oup.com
Uncertainty regarding the benefits of vertebroplasty (VP) for the treatment of acute osteoporotic
vertebral fractures has recently arisen. A prospective, controlled, randomized single‐…
vertebral fractures has recently arisen. A prospective, controlled, randomized single‐…
Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study.
BACKGROUND: Reduced bone mass predisposes patients to the development of vertebral
fractures. Measurement of bone mass by non-invasive methods is used to detect patients …
fractures. Measurement of bone mass by non-invasive methods is used to detect patients …
Mutations in the gene encoding the latency-associated peptide of TGF-β1 cause Camurati-Engelmann disease
…, R Gershoni-Baruch, N Guañabens, N Migone… - Nature …, 2000 - nature.com
Camurati-Engelmann disease (CED; MIM 131300), or progressive diaphyseal dysplasia, is
a rare, sclerosing bone dysplasia inherited in an autosomal dominant manner. Recently, the …
a rare, sclerosing bone dysplasia inherited in an autosomal dominant manner. Recently, the …
Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation
A Monegal, M Navasa, N Guanabens, P Peris… - Calcified Tissue …, 1997 - Springer
The purpose of this study was to determine the prevalence of osteoporosis, to estimate the
bone turnover and hormonal status, and to identify the factors associated with bone disease …
bone turnover and hormonal status, and to identify the factors associated with bone disease …
Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics
A Monegal, M Navasa, N Guanabens, P Peris… - Osteoporosis …, 2001 - Springer
After liver transplantation there is a high incidence of fractures, with important rates of bone
loss during the first months. However, the long-term evolution of bone mass and metabolism …
loss during the first months. However, the long-term evolution of bone mass and metabolism …
Comparative effects of teriparatide and risedronate in glucocorticoid‐induced osteoporosis in men: 18‐month results of the EuroGIOPs trial
…, JM Nolla, C Niedhart, N Guanabens… - Journal of bone and …, 2013 - academic.oup.com
Data on treatment of glucocorticoid‐induced osteoporosis (GIO) in men are scarce. We
performed a randomized, open‐label trial in men who have taken glucocorticoids (GC) for ≥3 …
performed a randomized, open‐label trial in men who have taken glucocorticoids (GC) for ≥3 …
Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis
N Guañabens, A Parés, I Ros, L Caballería, F Pons… - Journal of …, 2005 - Elsevier
BACKGROUND: Since primary biliary cirrhosis (PBC) is usually diagnosed in postmenopausal
women with minor cholestasis, it has been questioned whether PBC itself represents a …
women with minor cholestasis, it has been questioned whether PBC itself represents a …